Pfizer
-
COVID-19
FDA Approves First COVID-19 Vaccine
Approval Signifies Key Achievement for Public Health August 23, 2021 Today, the U.S. Food and Drug Administration approved the first…
Read More » -
COVID-19
COVID-19 vaccine distribution will begin within 24 hours of an emergency use authorization
November 18, 2020 / Mallory Hackett, Associate Editor Senior officials are confident in the distribution plan for an eventual COVID-19 vaccine,…
Read More » -
COVID-19
U.S. government engaging Pfizer to produce millions of COVID-19 vaccine doses
July 22, 2020 / Jeff Lagasse, Associate Editor The U.S. Department of Health and Human Services and the Department of Defense announced an…
Read More » -
Hospitals
Bioventus Receives ANVISA Approval to Market DUROLANE® in Brazil and Selects Pfizer as Exclusive Distribution Partner
October 02, 2018 HOOFDDORP, Netherlands–(BUSINESS WIRE)–Bioventus, a global leader in orthobiologic solutions, has received approval from Agência Nacional de Vigilância…
Read More » -
Spine
Pfizer continues study of Staphylococcus aureus vaccine for elective spinal fusion surgery
Pfizer Inc. announced the enrollment of the first patient in a Phase 2b clinical trial of its investigational Staphylococcus aureus multi-antigen vaccine…
Read More »